Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice

被引:35
作者
Nganou-Makamdop, Krystelle [1 ]
van Roosmalen, Maarten L. [2 ]
Audouy, Sandrine A. L. [3 ]
van Gemert, Geert-Jan [1 ]
Leenhouts, Kees [2 ]
Hermsen, Cornelus C. [1 ]
Sauerwein, Robert W. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Mucosis BV, Groningen, Netherlands
[3] BiOMaDe Technol Fdn, Groningen, Netherlands
关键词
BLP; CSP; Delivery platform; Immunization; Malaria; Plasmodium berghei; PRIME-BOOST IMMUNIZATION; CELL IMMUNE-RESPONSE; C-TERMINAL FRAGMENT; LACTOCOCCUS-LACTIS; GEM PARTICLES; T-CELLS; IRRADIATED SPOROZOITES; SYNTHETIC POLYPEPTIDE; VACCINE DEVELOPMENT; MURINE MALARIA;
D O I
10.1186/1475-2875-11-50
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Virus-like particles have been regularly used as an antigen delivery system for a number of Plasmodium peptides or proteins. The present study reports the immunogenicity and protective efficacy of bacterium-like particles (BLPs) generated from Lactococcus lactis and loaded with Plasmodium berghei circumsporozoite protein (PbCSP) peptides. Methods: A panel of BLP-PbCSP formulations differing in composition and quantity of B-cell, CD4+ and CD8+ T-cell epitopes of PbCSP were tested in BALB/c mice. Results: BLP-PbCSP1 induced specific humoral responses but no I Gamma N-gamma ELISPOT response, protecting 30-40% of the immunized mice. BLP-PbCSP2, with reduced length of the non-immunogenic part of the T-cell-epitopes construct, increased induction of IFN-gamma responses as well as protection up to 60-70%. Compared to controls, lower parasitaemia was observed in unprotected mice immunized with BLP-PbCSP1 or 2, suggestive for partial immunity. Finally, further increase of the number of B-cell epitopes and codon optimization (BLP-PbCSP4) induced the highest anti-CSP antibody levels and number of IFN-gamma spots, resulting in sterile immunity in 100% of the immunized mice. Conclusion: Presentation of Plasmodium derived antigens using BLPs as a delivery system induced complete protection in a murine malaria model. Eventually, BLPs have the potential to be used as a novel versatile delivery platform in malaria vaccine development.
引用
收藏
页数:11
相关论文
共 47 条
[1]   Development of lactococcal GEM-based pneumococcal vaccines [J].
Audouy, Sandrine A. L. ;
van Selm, Saskia ;
van Roosmalen, Maarten L. ;
Post, Eduard ;
Kanninga, Rolf ;
Neef, Jolanda ;
Estevao, Silvia ;
Nieuwenhuis, Edward E. S. ;
Adrian, Peter V. ;
Leenhouts, Kees ;
Hermans, Peter W. M. .
VACCINE, 2007, 25 (13) :2497-2506
[2]   Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization [J].
Audouy, Sandrine A. L. ;
van Roosmalen, Maarten L. ;
Neef, Jolanda ;
Kanninga, Rolf ;
Post, Eduard ;
van Deemter, Marielle ;
Metselaar, Heidi ;
van Selm, Saskia ;
Robillard, George T. ;
Leenhouts, Kees J. ;
Hermans, Peter W. M. .
VACCINE, 2006, 24 (26) :5434-5441
[3]   IMMUNOGENICITY OF SYNTHETIC PEPTIDES FROM CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM [J].
BALLOU, WR ;
ROTHBARD, J ;
WIRTZ, RA ;
GORDON, DM ;
WILLIAMS, JS ;
GORE, RW ;
SCHNEIDER, I ;
HOLLINGDALE, MR ;
BEAUDOIN, RL ;
MALOY, WL ;
MILLER, LH ;
HOCKMEYER, WT .
SCIENCE, 1985, 228 (4702) :996-999
[4]   Heterologous expression of plasmodial proteins for structural studies and functional annotation [J].
Birkholtz, Lyn-Marie ;
Blatch, Gregory ;
Coetzer, Theresa L. ;
Hoppe, Heinrich C. ;
Human, Esmare ;
Morris, Elizabeth J. ;
Ngcete, Zoleka ;
Oldfield, Lyndon ;
Roth, Robyn ;
Shonhai, Addmore ;
Stephens, Linda ;
Louw, Abraham I. .
MALARIA JOURNAL, 2008, 7 (1)
[5]   Novel surface display system for proteins on non-genetically modified gram-positive bacteria [J].
Bosma, T ;
Kanninga, R ;
Neef, J ;
Audouy, SAL ;
van Roosmalen, ML ;
Steen, A ;
Buist, G ;
Kok, J ;
Kuipers, OP ;
Robillard, G ;
Leenhouts, K .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (01) :880-889
[6]   Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif [J].
Bruna-Romero, O ;
Rocha, CD ;
Tsuji, M ;
Gazzinelli, RT .
VACCINE, 2004, 22 (27-28) :3575-3584
[7]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[8]   LysM, a widely distributed protein motif for binding to (peptido)glycans [J].
Buist, Girbe ;
Steen, Anton ;
Kok, Jan ;
Kuipers, Oscar R. .
MOLECULAR MICROBIOLOGY, 2008, 68 (04) :838-847
[9]   Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes [J].
Gilbert, SC ;
Schneider, J ;
Hannan, CM ;
Hu, JT ;
Plebanski, M ;
Sinden, R ;
Hill, AVS .
VACCINE, 2002, 20 (7-8) :1039-1045
[10]   Sterile Protection against Malaria Is Independent of Immune Responses to the Circumsporozoite Protein [J].
Gruener, Anne Charlotte ;
Mauduit, Marjorie ;
Tewari, Rita ;
Romero, Jackeline F. ;
Depinay, Nadya ;
Kayibanda, Michele ;
Lallemand, Eliette ;
Chavatte, Jean-Marc ;
Crisanti, Andrea ;
Sinnis, Photini ;
Mazier, Dominique ;
Corradin, Giampietro ;
Snounou, Georges ;
Renia, Laurent .
PLOS ONE, 2007, 2 (12)